Viewing Study NCT01614795


Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2025-12-28 @ 2:40 AM
Study NCT ID: NCT01614795
Status: COMPLETED
Last Update Posted: 2018-12-11
First Post: 2012-06-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
Sponsor: National Cancer Institute (NCI)
Organization: